New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|7|1097-1103

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.7, 2014-02, pp. : 1097-1103

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of gastric marginal zone lymphoma of MALT type

By Stathis Anastasios   Bertoni Francesco   Zucca Emanuele  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2141-2152

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Treatment of Corneal Neovascularization

By Keating Anne M.   Jacobs Deborah S.  

The Ocular Surface, Vol. 9, Iss. 4, 2011-10 ,pp. : 227-238

Ethis Communications

Access to resources Recommend Favorite

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkin's Lymphoma

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. : 301-311

Bentham Science Publishers

Access to resources Recommend Favorite

Moving Beyond VEGF for Anti-angiogenesis Strategies in Gynecologic Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2713-2719

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Aggregating Antibodies, a New Approach Towards Treatment of Conformational Diseases

By  

Current Medicinal Chemistry, Vol. 9, Iss. 19, 2002-10 ,pp. : 1737-1749

Bentham Science Publishers

Access to resources Recommend Favorite